ARGX vs. ATR: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at ARGX and ATR, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
ARGX trades as an American Depositary Receipt (ADR), offering U.S. investors a convenient way to access its foreign-listed shares. In contrast, ATR is a standard domestic listing.
| Symbol | ARGX | ATR |
|---|---|---|
| Company Name | argenx SE | AptarGroup, Inc. |
| Country | Netherlands | United States |
| GICS Sector | Health Care | Materials |
| GICS Industry | Biotechnology | Containers & Packaging |
| Market Capitalization | 42.15 billion USD | 9.32 billion USD |
| Exchange | NasdaqGS | NYSE |
| Listing Date | May 18, 2017 | April 23, 1993 |
| Security Type | ADR | Common Stock |
Historical Performance
This chart compares the performance of ARGX and ATR by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
| Symbol | ARGX | ATR |
|---|---|---|
| 5-Day Price Return | -1.36% | -0.02% |
| 13-Week Price Return | 8.64% | -10.91% |
| 26-Week Price Return | -8.57% | -5.09% |
| 52-Week Price Return | 22.32% | -6.33% |
| Month-to-Date Return | -4.85% | -11.19% |
| Year-to-Date Return | -5.73% | -11.16% |
| 10-Day Avg. Volume | 0.07M | 0.49M |
| 3-Month Avg. Volume | 0.08M | 0.39M |
| 3-Month Volatility | 37.04% | 26.54% |
| Beta | 0.77 | 0.58 |
Profitability
Return on Equity (TTM)
ARGX
17.59%
Biotechnology Industry
- Max
- 77.14%
- Q3
- 10.76%
- Median
- -20.08%
- Q1
- -42.71%
- Min
- -119.20%
In the upper quartile for the Biotechnology industry, ARGX’s Return on Equity of 17.59% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.
ATR
15.28%
Containers & Packaging Industry
- Max
- 41.66%
- Q3
- 20.76%
- Median
- 14.35%
- Q1
- 6.55%
- Min
- 3.64%
ATR’s Return on Equity of 15.28% is on par with the norm for the Containers & Packaging industry, indicating its profitability relative to shareholder equity is typical for the sector.
Net Profit Margin (TTM)
ARGX
-23.60%
Biotechnology Industry
- Max
- 59.44%
- Q3
- 16.21%
- Median
- -11.49%
- Q1
- -167.42%
- Min
- -409.07%
ARGX has a negative Net Profit Margin of -23.60%, indicating the company is operating at a net loss as its expenses exceeded its revenues.
ATR
10.84%
Containers & Packaging Industry
- Max
- 11.61%
- Q3
- 8.17%
- Median
- 4.91%
- Q1
- 4.20%
- Min
- 0.08%
A Net Profit Margin of 10.84% places ATR in the upper quartile for the Containers & Packaging industry, signifying strong profitability and more effective cost management than most of its peers.
Operating Profit Margin (TTM)
ARGX
-40.34%
Biotechnology Industry
- Max
- 60.62%
- Q3
- 20.76%
- Median
- -12.41%
- Q1
- -181.14%
- Min
- -482.02%
ARGX has a negative Operating Profit Margin of -40.34%. This signifies the company is unprofitable at the operational level, as its core business expenses exceed its revenue.
ATR
14.30%
Containers & Packaging Industry
- Max
- 22.03%
- Q3
- 13.17%
- Median
- 8.87%
- Q1
- 6.86%
- Min
- 0.07%
An Operating Profit Margin of 14.30% places ATR in the upper quartile for the Containers & Packaging industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.
Profitability at a Glance
| Symbol | ARGX | ATR |
|---|---|---|
| Return on Equity (TTM) | 17.59% | 15.28% |
| Return on Assets (TTM) | 15.24% | 8.49% |
| Net Profit Margin (TTM) | -23.60% | 10.84% |
| Operating Profit Margin (TTM) | -40.34% | 14.30% |
| Gross Profit Margin (TTM) | 90.83% | 38.32% |
Financial Strength
Current Ratio (MRQ)
ARGX
5.60
Biotechnology Industry
- Max
- 19.31
- Q3
- 9.38
- Median
- 4.54
- Q1
- 2.45
- Min
- 0.76
ARGX’s Current Ratio of 5.60 aligns with the median group of the Biotechnology industry, indicating that its short-term liquidity is in line with its sector peers.
ATR
1.21
Containers & Packaging Industry
- Max
- 2.13
- Q3
- 1.57
- Median
- 1.27
- Q1
- 1.13
- Min
- 0.58
ATR’s Current Ratio of 1.21 aligns with the median group of the Containers & Packaging industry, indicating that its short-term liquidity is in line with its sector peers.
Debt-to-Equity Ratio (MRQ)
ARGX
0.01
Biotechnology Industry
- Max
- 1.35
- Q3
- 0.64
- Median
- 0.09
- Q1
- 0.00
- Min
- 0.00
ARGX’s Debt-to-Equity Ratio of 0.01 is typical for the Biotechnology industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
ATR
0.40
Containers & Packaging Industry
- Max
- 4.50
- Q3
- 2.23
- Median
- 1.22
- Q1
- 0.54
- Min
- 0.23
Falling into the lower quartile for the Containers & Packaging industry, ATR’s Debt-to-Equity Ratio of 0.40 points to a conservative financing strategy. This results in lower financial risk but potentially limits strategic investments compared to more leveraged competitors.
Interest Coverage Ratio (TTM)
ARGX
-81.88
Biotechnology Industry
- Max
- 72.37
- Q3
- 1.91
- Median
- -7.81
- Q1
- -63.90
- Min
- -153.80
ARGX has a negative Interest Coverage Ratio of -81.88. This indicates that its earnings were insufficient to cover even its operational costs, let alone its interest payments, signaling significant financial distress.
ATR
16.66
Containers & Packaging Industry
- Max
- 13.16
- Q3
- 8.10
- Median
- 3.61
- Q1
- 2.94
- Min
- 1.06
With an Interest Coverage Ratio of 16.66, ATR demonstrates a superior capacity to service its debt, placing it well above the typical range for the Containers & Packaging industry. This stems from either robust earnings or a conservative debt load.
Financial Strength at a Glance
| Symbol | ARGX | ATR |
|---|---|---|
| Current Ratio (MRQ) | 5.60 | 1.21 |
| Quick Ratio (MRQ) | 4.92 | 0.83 |
| Debt-to-Equity Ratio (MRQ) | 0.01 | 0.40 |
| Interest Coverage Ratio (TTM) | -81.88 | 16.66 |
Growth
Revenue Growth
EPS Growth
Dividend
Dividend Yield (TTM)
ARGX
0.00%
Biotechnology Industry
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
ARGX currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.
ATR
1.30%
Containers & Packaging Industry
- Max
- 7.37%
- Q3
- 4.07%
- Median
- 3.33%
- Q1
- 1.72%
- Min
- 0.00%
ATR’s Dividend Yield of 1.30% is in the lower quartile for the Containers & Packaging industry. This suggests the company’s strategy likely favors retaining earnings for growth over providing a high dividend income.
Dividend Payout Ratio (TTM)
ARGX
0.00%
Biotechnology Industry
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
ARGX has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.
ATR
30.51%
Containers & Packaging Industry
- Max
- 221.20%
- Q3
- 119.52%
- Median
- 58.05%
- Q1
- 28.91%
- Min
- 0.00%
ATR’s Dividend Payout Ratio of 30.51% is within the typical range for the Containers & Packaging industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
Dividend at a Glance
| Symbol | ARGX | ATR |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 1.30% |
| Dividend Payout Ratio (TTM) | 0.00% | 30.51% |
Valuation
Price-to-Earnings Ratio (TTM)
ARGX
31.14
Biotechnology Industry
- Max
- 60.14
- Q3
- 38.17
- Median
- 29.01
- Q1
- 15.12
- Min
- 0.00
ARGX’s P/E Ratio of 31.14 is within the middle range for the Biotechnology industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
ATR
23.49
Containers & Packaging Industry
- Max
- 35.98
- Q3
- 27.87
- Median
- 16.15
- Q1
- 14.38
- Min
- 8.20
ATR’s P/E Ratio of 23.49 is within the middle range for the Containers & Packaging industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
Price-to-Sales Ratio (TTM)
ARGX
29.31
Biotechnology Industry
- Max
- 76.98
- Q3
- 36.53
- Median
- 9.49
- Q1
- 4.49
- Min
- 0.00
ARGX’s P/S Ratio of 29.31 aligns with the market consensus for the Biotechnology industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
ATR
2.55
Containers & Packaging Industry
- Max
- 2.91
- Q3
- 1.67
- Median
- 0.83
- Q1
- 0.64
- Min
- 0.30
ATR’s P/S Ratio of 2.55 is in the upper echelon for the Containers & Packaging industry. This means the company is valued richly on its revenue stream compared to its peers, suggesting the stock is priced for a high level of future performance.
Price-to-Book Ratio (MRQ)
ARGX
5.48
Biotechnology Industry
- Max
- 20.53
- Q3
- 9.76
- Median
- 4.77
- Q1
- 2.49
- Min
- 0.59
ARGX’s P/B Ratio of 5.48 is within the conventional range for the Biotechnology industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
ATR
3.83
Containers & Packaging Industry
- Max
- 5.28
- Q3
- 3.30
- Median
- 2.35
- Q1
- 1.57
- Min
- 0.89
ATR’s P/B Ratio of 3.83 is in the upper tier for the Containers & Packaging industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.
Valuation at a Glance
| Symbol | ARGX | ATR |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | 31.14 | 23.49 |
| Price-to-Sales Ratio (TTM) | 29.31 | 2.55 |
| Price-to-Book Ratio (MRQ) | 5.48 | 3.83 |
| Price-to-Free Cash Flow Ratio (TTM) | -- | 26.92 |